Annual report pursuant to Section 13 and 15(d)

- Summary Estimated Fair Value of Assets and Liabilities Assumed (Details)

v2.4.0.8
- Summary Estimated Fair Value of Assets and Liabilities Assumed (Details) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Intangible assets:      
Goodwill $ 226,373 [1] $ 80,450 [1] $ 39,815
OURLab [Member]
     
Business Acquisition [Line Items]      
Current assets 6,020    
Intangible assets:      
Customer relationships 3,860    
Technology 1,370    
In-process research and development 0    
Product registrations 0    
Licenses 70    
Covenants not to compete 6,900    
Tradename 1,830    
Total intangible assets 14,030    
Goodwill 29,629    
Property, plant and equipment 2,117    
Other assets 37    
Accounts payable and accrued expenses (3,214)    
Deferred tax liability (6,356)    
Debt assumed 0    
Total purchase price 42,263    
Farmadiet [Member]
     
Business Acquisition [Line Items]      
Current assets 8,367    
Intangible assets:      
Customer relationships 436    
Technology 3,017    
In-process research and development 1,459    
Product registrations 2,930    
Licenses 0    
Covenants not to compete 187    
Tradename 349    
Total intangible assets 8,378    
Goodwill 8,062    
Property, plant and equipment 7,205    
Other assets 611    
Accounts payable and accrued expenses (3,438)    
Deferred tax liability (3,169)    
Debt assumed (7,829)    
Total purchase price 18,187    
ALS Acquisition [Member]
     
Business Acquisition [Line Items]      
Current assets 767    
Intangible assets:      
Customer relationships 0    
Technology 0    
In-process research and development 0    
Product registrations 2,300    
Licenses 0    
Covenants not to compete 0    
Tradename 680    
Total intangible assets 2,980    
Goodwill 458    
Property, plant and equipment 24    
Other assets 0    
Accounts payable and accrued expenses (229)    
Deferred tax liability 0    
Debt assumed 0    
Total purchase price $ 4,000    
[1] As of December 31, 2013 and 2012, total assets include $6.7 million and $5.6 million, respectively, and total liabilities include $10.4 million and $5.5 million, respectively related to SciVac Ltd (“SciVac”), previously known as SciGen (I.L.) Ltd, a consolidated variable interest entity. SciVac’s consolidated assets are owned by SciVac and the holders of SciVac’s consolidated liabilities have no recourse against us. Refer to Note 3.